Filing Flows › DexCom (DXCM) › Q2 2025
DexCom (DXCM) Q2 2025 earnings results (second quarter 2025)
10-Q filed Jul 30, 2025
DexCom (DXCM) reported revenue of $1.2B for the second quarter 2025 (Q2 2025), +15% from a year earlier and +12% from the quarter before. Operating margin was 18.4%, net earnings $180M (15.5% of revenue).
DexCom, Q2 2025: revenue $1.2B (+15% year over year), operating margin 18.4%, net earnings $180M, operating cash flow $303M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2B | +12% | +15% |
| Gross profit | $689M | +17% | +10% |
| Operating profit | $213M | +59% | +35% |
| Net earnings | $180M | +71% | +25% |
| Operating cash flow | $303M | +65% | +8% |
| Free cash flow | $209M | +116% | -2% |
What changed
Revenue was $1.2B in Q2 2025, up 15% year over year and up 12% from the previous quarter.
Gross margin was 59.5%, down 2.9 points from a year earlier. Operating profit was $0.21B, a 18.4% margin (up 2.6 points year over year). Of the extra revenue versus a year earlier, 36% reached operating profit, above the 16% margin then. Operating expenses grew 2% against revenue growth of 15%. Net earnings were $0.18B, up 25% year over year. The effective tax rate was 25.4%.
Operating cash flow was $0.30B (up 8% year over year), 169% of net earnings. Non-cash charges added back $0.06B of depreciation and amortization and $0.05B of share-based compensation. Capital expenditures of $0.09B left free cash flow of $0.21B.
Questions
What was DexCom's revenue in the second quarter 2025?
DexCom (DXCM) reported revenue of $1.2B for the second quarter 2025 (Q2 2025), +15% from a year earlier and +12% from the quarter before.
Was DexCom profitable in the second quarter 2025?
Operating profit was $213M (18.4% of revenue) and net earnings $180M.
Source: DexCom 10-Q on SEC EDGAR.